October 1, 2019 The Retina Foundation of the Southwest is one of four U.S. centers conducting a Phase 1/2 dose escalation, gene replacement trial for x-linked retinitis pigmentosa (XLRP). On September 26th, the clinical trial sponsor, Applied Genetic Technologies Corporation …
September 26, 2019 Ruvanthi Kularatne, Ph.D., is a Postdoctoral Fellow at the Retina Foundation of the Southwest, working under the direction of Karl Csaky, M.D., Ph.D., Managing & Medical Director. Dr. Kularatne has spent the past year evaluating the effectiveness …
August 15, 2019 We are pleased to announce Krista Kelly, Ph.D. as Director of the Vision and Neurodevelopment Laboratory! Dr. Krista Kelly received her Ph.D. from York University in 2014 before joining the Retina Foundation of the Southwest as a …
August 2, 2019 Age-related macular degeneration (AMD) has multiple stages of progression. The “dry” form is characterized by yellow deposits called drusen, that grow in size and number, leading to dimmed or distorted vision. There are currently no treatments for …
July 31, 2019 The Retina Foundation is an international leader in research on lazy eye, the most common cause of visual impairment in children. A new treatment we are working on in collaboration with Mayo Clinic has the goal of …
July 23, 2019 In a clinical research study headed by Dr. David Birch, scientists in the Rose-Silverthorne Retinal Degenerations Lab are testing the efficacy of gene therapy in patients with choroideremia. This late stage trial is based on early Phase …
July 19, 2019 Yi-Zhong Wang, Ph.D., Scientific Director, Macular Function Laboratory, is working to achieve automatic and accurate identification of defects in the structure of patients’ retinas by applying deep machine learning method. Over the past year, using a cutting-edge …
May 20, 2019 Jenny Schisler has retinitis pigmentosa. Jenny wants to spread awareness of what having a visual impairment really means to her and others affected by retinal degenerative diseases. By Jenny Schisler There was recently a viral image of …
May 13, 2019 The Molecular Ophthalmology Laboratory, under the direction of Dr. Karl Csaky, Managing & Medical Director at the Retina Foundation of the Southwest, is studying live cell cultures to investigate new potential drug treatments for age-related macular degeneration …
April 8, 2019 The Retina Foundation of the Southwest acquired and renovated a new clinical research center in Dallas, Texas thanks to tremendous help from the Board of Directors and generous support from foundations, companies, and individuals. Join us at …
April 1, 2019 The Retina Foundation of the Southwest is pleased to announce the on-boarding of eight new Board members, who recently joined 19 existing members to oversee our efforts and ensure that we are working efficiently to advance our …
March 18, 2019 Since 1982, the Retina Foundation of the Southwest has been researching pediatric eye conditions to help infants and children with lazy eye, crossed eyes, cataracts, and other conditions. On March 18, 2019, our 10,000th patient completed his …
November 8, 2018 The Retina Foundation of the Southwest and Rebion, a technology company in Boston, Massachusetts, created, evaluated, and received FDA approval for the Pediatric Vision Screener (PVS), a device that quickly and accurately evaluates the vision of children …
November 7, 2018 The Retina Foundation of the Southwest was the first site in the world to enroll patients in a new international Phase III Clinical Treatment Trial for Stargardt Disease sponsored by the clinical-stage ophthalmology company Acucela. This study …
October 2, 2018 Age-related macular degeneration (AMD) is a common disease associated with aging that gradually impairs sharp, central vision that is necessary for everyday tasks such as reading, writing, and driving. There are two common forms of AMD: dry …
